Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
39,205,892
-
Share change
-
+2,445,017
-
Total reported value
-
$3,161,175,854
-
Put/Call ratio
-
39%
-
Price per share
-
$80.64
-
Number of holders
-
237
-
Value change
-
+$214,185,579
-
Number of buys
-
115
-
Number of sells
-
117
Institutional Holders of CANTEL MEDICAL CORP - COM (CMD) as of Q2 2019
As of 30 Jun 2019,
CANTEL MEDICAL CORP - COM (CMD) was held by
237 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,205,892 shares.
The largest 10 holders included
BROWN CAPITAL MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, WASATCH ADVISORS INC, Champlain Investment Partners, LLC, JANUS HENDERSON GROUP PLC, Conestoga Capital Advisors, LLC, Neuberger Berman Group LLC, MACKENZIE FINANCIAL CORP, and FRED ALGER MANAGEMENT INC.
This page lists
237
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.